Major pharmaceutical companies and service providers–CMOs/CROs–are already employing multiple Gyrolab systems to boost their drug development process and meet increasing regulatory demands.
| • |  |
Up throughput |
| • | |
Up efficiency and effectiveness |
| • | |
Upgrade your current Gyrolab system to encompass the full extended performance level of the new Gyrolab xP |
| • | |
Up-to-standard on performance and regulatory requirements |
|